1. Home
  2. LEXX vs LEE Comparison

LEXX vs LEE Comparison

Compare LEXX & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • LEE
  • Stock Information
  • Founded
  • LEXX 2004
  • LEE 1890
  • Country
  • LEXX Canada
  • LEE United States
  • Employees
  • LEXX N/A
  • LEE N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • LEXX Health Care
  • LEE Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • LEE Nasdaq
  • Market Cap
  • LEXX 19.6M
  • LEE 38.2M
  • IPO Year
  • LEXX N/A
  • LEE N/A
  • Fundamental
  • Price
  • LEXX $0.87
  • LEE $6.38
  • Analyst Decision
  • LEXX Strong Buy
  • LEE
  • Analyst Count
  • LEXX 1
  • LEE 0
  • Target Price
  • LEXX $5.00
  • LEE N/A
  • AVG Volume (30 Days)
  • LEXX 145.3K
  • LEE 35.4K
  • Earning Date
  • LEXX 07-15-2025
  • LEE 07-31-2025
  • Dividend Yield
  • LEXX N/A
  • LEE N/A
  • EPS Growth
  • LEXX N/A
  • LEE N/A
  • EPS
  • LEXX N/A
  • LEE N/A
  • Revenue
  • LEXX $525,923.00
  • LEE $591,094,000.00
  • Revenue This Year
  • LEXX $0.62
  • LEE N/A
  • Revenue Next Year
  • LEXX $14.19
  • LEE N/A
  • P/E Ratio
  • LEXX N/A
  • LEE N/A
  • Revenue Growth
  • LEXX 29.95
  • LEE N/A
  • 52 Week Low
  • LEXX $0.82
  • LEE $5.83
  • 52 Week High
  • LEXX $4.38
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 41.33
  • LEE 44.10
  • Support Level
  • LEXX $0.83
  • LEE $6.04
  • Resistance Level
  • LEXX $1.05
  • LEE $6.78
  • Average True Range (ATR)
  • LEXX 0.07
  • LEE 0.43
  • MACD
  • LEXX -0.00
  • LEE 0.05
  • Stochastic Oscillator
  • LEXX 35.09
  • LEE 47.01

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: